Xenon Pharmaceuticals Inc

(NASDAQ:XENE)

Latest On Xenon Pharmaceuticals Inc (XENE):

Date/Time Type Description Signal Details
2023-05-23 19:33 ESTNewsXenon Pharmaceuticals: Navigating The Neural Network Of Epilepsy And DepressionN/A
2023-05-13 22:20 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 20:01 ESTNewsXenon Pharma GAAP EPS of -$0.63 beats by $0.01N/A
2023-05-09 05:53 ESTNewsXenon Pharma Q1 2023 Earnings PreviewN/A
2023-03-15 18:51 ESTNewsXenon May Have A Surprise In Store For Major Depressive DisorderN/A
2023-03-02 08:45 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 18:23 ESTNewsXenon Pharma GAAP EPS of -$0.57 beats by $0.02N/A
2023-03-01 03:05 ESTNewsXenon Pharma Q4 2022 Earnings PreviewN/A
2023-02-08 14:29 ESTNewsXenon Pharmaceuticals: De-Risked Late-Stage Neurology Biotech, BuyN/A
2022-12-23 16:03 ESTNewsXenon Pharmaceuticals: Momentum Still Accelerating, Rate Buy (Technical Analysis)N/A
2022-11-28 20:23 ESTNewsXenon initiated Overweight at Wells Fargo on prospects in depressionN/A
2022-11-08 21:25 ESTNewsXenon Pharma GAAP EPS of -$0.57 misses by $0.05, revenue of $0.13M misses by $2.89MN/A
2022-11-08 21:24 ESTNewsXenon Pharmaceuticals Inc. (XENE) Q3 2022 Earnings Call TranscriptN/A
2022-10-19 16:36 ESTNewsXenon started at outperform at Raymond James on experimental epilepsy drugN/A
2022-09-06 17:12 ESTNewsPutting Xenon Pharmaceuticals Back In The SpotlightN/A
2022-08-29 20:33 ESTNewsXenon initiated with Buy at BofA citing potential of anti-seizure drugN/A
2022-08-11 01:42 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 07:40 ESTNewsXenon Pharma GAAP EPS of -$0.55 misses by $0.06, revenue of $0.54M misses by $2.71MN/A
2022-08-09 11:57 ESTNewsXenon Pharma Q2 2022 Earnings PreviewN/A
2022-07-22 07:20 ESTNewsXenon added to JP Morgan’s analyst focus list citing lead assetN/A
2022-06-23 22:26 ESTNewsXenon Pharmaceuticals slides on pricing $250M equity offeringN/A
2022-06-23 22:26 ESTNewsHot Stocks: OXY rises as Buffett adds shares, SNOW pops on upgrade, KBH also gains and XENE declinesN/A
2022-06-23 03:58 ESTNewsXenon slips 11% on public offering of common stockN/A
2022-05-11 12:48 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 17:11 ESTNewsXenon Pharma GAAP EPS of -$0.35 beats by $0.07, revenue of $8.77M beats by $1.03MN/A
2022-05-09 19:04 ESTNewsXenon Pharmaceuticals Q1 Earnings PreviewN/A
2022-03-02 08:46 ESTNewsXenon Pharma GAAP EPS of -$1.77 misses by $1.41, revenue of $18.43M beats by $12.13MN/A
2022-03-02 08:46 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-19 20:02 ESTNewsXenon draws buyout speculation after Zogenix dealN/A
2022-01-12 13:22 ESTNewsXenon passes regulatory mark to receive $15M from Neurocrine BiosciencesN/A
2021-12-14 04:59 ESTNewsSizing Up Xenon PharmaceuticalsN/A
2021-12-11 00:58 ESTNewsXenon Pharmaceuticals (XENE) Presents At AES 2021 SymposiumN/A
2021-12-08 15:45 ESTNewsXenon Pharmaceuticals jumps 5% on insider buying worth $100KN/A
2021-12-07 00:52 ESTNewsXenon Pharmaceuticals (XENE) Investor Presentation - SlideshowN/A
2021-12-03 23:16 ESTNewsXenon Pharma presents additional positive data from Phase 2b X-TOLE trial at AES 2021N/A
2021-11-11 15:47 ESTNewsXenon Pharmaceuticals' (XENE) CEO Ian Mortimer on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 18:37 ESTNewsXenon Pharma EPS beats by $0.01, misses on revenueN/A
2021-11-09 19:56 ESTNewsXenon Pharma Q3 2021 Earnings PreviewN/A
2021-10-06 21:06 ESTNewsXenon Pharma secures $300M capital raise via equity offeringN/A
2021-10-05 18:52 ESTNewsXenon Pharmaceuticals rises ~4% amid launch of $250M stock offeringN/A
2021-10-04 16:06 ESTNewsXenon Pharma stock jumps 80% on positive XEN1101 data in mid-stage focal epilepsy studyN/A
2021-09-08 18:36 ESTNewsXenon Pharmaceuticals gets $10M milestone payment from Neurocrine collaborationN/A
2021-08-23 17:59 ESTNewsNew medical chief at Xenon PharmaN/A
2021-08-12 06:35 ESTNewsXenon Pharma EPS misses by $0.03, misses on revenueN/A
2021-08-12 06:34 ESTNewsXenon Pharmaceuticals Inc. (XENE) CEO Ian Mortimer on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-22 09:06 ESTNewsXenon completes patient randomization in mid-stage XEN1101 epilepsy trialN/A
2021-03-10 02:08 ESTNewsXenon Pharmaceuticals readies stock offeringN/A
2021-03-10 02:08 ESTNewsXenon Pharma secures $100M via equity raiseN/A
2021-03-09 06:58 ESTNewsXenon strikes research deal for major depressive disorder treatment XEN1101N/A
2021-03-04 12:48 ESTAnalyst RatingThe Analyst Target Price has increased from $25 to $25.29.Buy

About Xenon Pharmaceuticals Inc (XENE):

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel modulator that is Phase III clinical trials for the treatment of KCNQ2 epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel modulator, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop FX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. The company was incorporated in 1996 and is headquartered in Burnaby, Canada.

XENE Quotes by TradingView

See Advanced Chart

General

  • Name Xenon Pharmaceuticals Inc
  • Symbol XENE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 123
  • Fiscal Year EndDecember
  • IPO Date2014-11-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.xenon-pharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 20.81
  • Price/Book (Most Recent Quarter) 4.24
  • Enterprise Value Revenue 16.42
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Next Quarter EPS Estimate -$0.45
  • Profit Margin -90%
  • Operating Margin -97%
  • Return on Assets -12%
  • Return on Equity -22%
  • Revenue 32.17 million
  • Earnings Per Share -$1.72
  • Revenue Per Share $0.93
  • Gross Profit -18357000
  • Quarterly Earnings Growth 54.7%
View More

Highlights

  • Market Capitalization 658.17 million
  • EBITDA -44423000
  • PE Ratio -18.63
  • PEG Ratio -0.06
  • Analyst Target Price $25.29
  • Book Value Per Share $4.67
View More

Share Statistics

  • Shares Outstanding 35.81 million
  • Shares Float 23.33 million
  • % Held by Insiders 658%
  • % Held by Institutions 81.3%
  • Shares Short 943938
  • Shares Short Prior Month 977125
  • Short Ratio 5.34
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.42
  • 52 Week High $21.94
  • 52 Week Low $8.95
  • 50 Day Moving Average 17.43
  • 200 Day Moving Average 13.52
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Xenon Pharmaceuticals Inc (XENE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Xenon Pharmaceuticals Inc (XENE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$5.15 million-$0.34-$0.4015%
2020-09-302020-11-05$N/A-$0.25-$0.17-47.06%
2020-06-302020-08-06$N/A$-0.00-$0.2097.52%
2020-03-312020-05-21$7.08 million-$0.22-$0.3129.6%
2019-12-312020-03-09$3.33 million-$0.41$0.12-441.67%
2019-09-302019-11-05$3.5 million-$0.33-$0.4628.26%
2019-06-302019-08-06$N/A-$0.37-$0.4518.38%
2019-03-312019-05-07$N/A-$0.42-$0.37-13.51%
2018-12-312019-03-06$N/A-$0.29-$0.3619.44%
2018-09-302018-11-06$N/A-$0.63-$0.40-57.5%
2018-06-302018-08-07$N/A-$0.45-$0.498.16%
2018-03-312018-05-08$N/A-$0.46-$0.484.96%
2017-12-312018-03-07$16000-$0.45-$0.44-2.27%
2017-09-302017-11-07$264000-$0.43-$0.39-10.26%
2017-06-302017-08-03$15000-$0.41-$0.39-6.03%
2017-03-312017-05-09$16000-$0.42-$0.38-9.57%
2016-12-312017-03-08$376000-$0.32-$0.4223.21%
2016-09-302016-11-03$413000-$0.51-$0.44-15.25%
2016-06-302016-08-03$413000-$0.42-$0.5016%
2016-03-312016-05-10$601000-$0.23-$0.21-9.52%
2015-12-312016-03-08$3.23 million-$0.27-$0.26-3.85%
2015-09-302015-11-10$4.29 million-$0.27-$0.01-2600%
2015-06-302015-08-10$4.05 million$0.08-$0.15153.33%
2015-03-312015-05-12$4.01 million-$0.30$0.14-314.29%
2014-12-312015-03-12$4.88 million$2.54-$0.0125500%
2014-09-302014-12-15$13.19 million$1.69

Xenon Pharmaceuticals Inc (XENE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Xenon Pharmaceuticals Inc (XENE) Chart:

Xenon Pharmaceuticals Inc (XENE) News:

Below you will find a list of latest news for Xenon Pharmaceuticals Inc (XENE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Xenon Pharmaceuticals Inc (XENE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-07-1817.50CALL0 0296.59TRUE00
2025-07-182013CALL0 5108.8TRUE00
2025-07-1822.50CALL0 0204.91TRUE00
2025-07-18250CALL0 053.12TRUE00
2025-07-1827.54.2CALL0 261.34TRUE00
2025-07-18303.12CALL0 1251.08TRUE00
2025-07-1832.51.2CALL0 855.53FALSE00
2025-07-18350CALL0 1171.99FALSE00
2025-07-1837.50CALL0 188.75FALSE00
2025-07-18400.05CALL0 10869.2FALSE00
2025-07-1842.50.09CALL0 87122.3FALSE00
2025-07-18450.1CALL0 31129.87FALSE00
2025-07-1847.50CALL0 2149.78FALSE00
2025-07-18500.04CALL86 288981.32FALSE00
2025-07-18550CALL0 2183.13FALSE00
2025-07-18600CALL0 3201.78FALSE00
2025-07-1817.50PUT0 5154.55FALSE00
2025-07-18200.17PUT0 2113.88FALSE00
2025-07-1822.50PUT0 1165.08FALSE00
2025-07-18250.25PUT0 8134.81FALSE00
2025-07-1827.50PUT0 4104.26FALSE00
2025-07-18300.7PUT0 121456.87FALSE00
2025-07-1832.50PUT0 058.01TRUE00
2025-07-18350PUT0 754.55TRUE00
2025-07-1837.50PUT0 180063.08TRUE00
2025-07-18400PUT0 4129.47TRUE00
2025-07-1842.50PUT0 080.59TRUE00
2025-07-18450PUT0 088.2TRUE00
2025-07-1847.50PUT0 098.93TRUE00
2025-07-18500PUT0 0129.57TRUE00
2025-07-18550PUT0 0126.89TRUE00
2025-07-18600PUT0 0136.07TRUE00
2025-08-1517.50CALL0 0195.1TRUE00
2025-08-15200CALL0 0162.82TRUE00
2025-08-1522.50CALL0 044.51TRUE00
2025-08-15250CALL0 050.92TRUE00
2025-08-1527.50CALL0 052.51TRUE00
2025-08-15300CALL0 049.06TRUE00
2025-08-1532.52.4CALL0 62047.44FALSE00
2025-08-15350CALL0 053.68FALSE00
2025-08-1537.50CALL0 065.5FALSE00
2025-08-15400CALL0 074.44FALSE00
2025-08-1542.50CALL0 083.36FALSE00
2025-08-15450CALL0 091.63FALSE00
2025-08-1547.50CALL0 099.62FALSE00
2025-08-1517.50PUT0 0161.03FALSE00
2025-08-15200PUT0 0134.7FALSE00
2025-08-1522.50PUT0 0112.01FALSE00
2025-08-15250PUT0 091.68FALSE00
2025-08-1527.50PUT0 075.36FALSE00
2025-08-15301.5PUT5 054.75FALSE1.50
2025-08-1532.50PUT0 051.58TRUE00
2025-08-15350PUT0 052.01TRUE00
2025-08-1537.50PUT0 052.43TRUE00
2025-08-15400PUT0 055.06TRUE00
2025-08-1542.50PUT0 058.91TRUE00
2025-08-15450PUT0 064.97TRUE00
2025-08-1547.50PUT0 069.73TRUE00
2025-10-17150CALL0 0152.13TRUE00
2025-10-1717.50CALL0 0129.96TRUE00
2025-10-17200CALL0 047.24TRUE00
2025-10-1722.50CALL0 051.45TRUE00
2025-10-17250CALL0 052.76TRUE00
2025-10-1727.50CALL0 052.49TRUE00
2025-10-17300CALL0 551.15TRUE00
2025-10-1732.53.8CALL0 3249.3FALSE00
2025-10-17353.02CALL0 1050.82FALSE00
2025-10-1737.50CALL0 051.96FALSE00
2025-10-17400CALL0 3055.89FALSE00
2025-10-1742.50CALL0 160.22FALSE00
2025-10-17450CALL0 2864.28FALSE00
2025-10-1747.50CALL0 568.38FALSE00
2025-10-17500CALL0 372.82FALSE00
2025-10-17550CALL0 280.83FALSE00
2025-10-17150PUT0 079.36FALSE00
2025-10-1717.50PUT0 085.84FALSE00
2025-10-17200PUT0 093.49FALSE00
2025-10-1722.50PUT0 180.48FALSE00
2025-10-17250PUT0 170.96FALSE00
2025-10-1727.50PUT0 061.52FALSE00
2025-10-17303.76PUT0 3656.99FALSE00
2025-10-1732.50PUT0 053.55TRUE00
2025-10-17350PUT0 053.11TRUE00
2025-10-1737.50PUT0 754.86TRUE00
2025-10-17400PUT0 354.64TRUE00
2025-10-1742.50PUT0 054.32TRUE00
2025-10-17450PUT0 055.67TRUE00
2025-10-1747.50PUT0 059.09TRUE00
2025-10-17500PUT0 058.36TRUE00
2025-10-17550PUT0 067.64TRUE00
2025-12-19150CALL0 0128.02TRUE00
2025-12-1917.50CALL0 041.43TRUE00
2025-12-19200CALL0 047.27TRUE00
2025-12-1922.50CALL0 2551.04TRUE00
2025-12-19250CALL0 5252.54TRUE00
2025-12-1927.50CALL0 7753.74TRUE00
2025-12-19300CALL0 2653.04TRUE00
2025-12-1932.50CALL0 451.67FALSE00
2025-12-19353.2CALL0 2750.07FALSE00
2025-12-1937.53.3CALL0 10550.03FALSE00
2025-12-19400CALL0 14349.55FALSE00
2025-12-1942.50CALL0 5651.49FALSE00
2025-12-19450CALL0 2854.34FALSE00
2025-12-1947.50CALL0 3057.13FALSE00
2025-12-19500CALL0 560.07FALSE00
2025-12-1952.50CALL0 163.35FALSE00
2025-12-19550CALL0 3165.88FALSE00
2025-12-19600.8CALL0 471.76FALSE00
2025-12-19650CALL0 376.79FALSE00
2025-12-19150.3PUT0 277.76FALSE00
2025-12-1917.50PUT0 372.11FALSE00
2025-12-19200PUT0 477.4FALSE00
2025-12-1922.50PUT0 266.74FALSE00
2025-12-19250PUT0 260.16FALSE00
2025-12-1927.50PUT0 159.24FALSE00
2025-12-19300PUT0 2055.01FALSE00
2025-12-1932.50PUT0 255.87TRUE00
2025-12-19350PUT0 152.48TRUE00
2025-12-1937.50PUT0 1253.25TRUE00
2025-12-19400PUT0 1652.73TRUE00
2025-12-1942.50PUT0 152.28TRUE00
2025-12-19450PUT0 451.45TRUE00
2025-12-1947.50PUT0 053.11TRUE00
2025-12-19500PUT0 054.75TRUE00
2025-12-1952.50PUT0 056.67TRUE00
2025-12-19550PUT0 057.93TRUE00
2025-12-19600PUT0 061.42TRUE00
2025-12-19650PUT0 067.62TRUE00
2026-01-16150CALL0 0118.21TRUE00
2026-01-1617.50CALL0 048.41TRUE00
2026-01-16200CALL0 052.79TRUE00
2026-01-1622.50CALL0 054.83TRUE00
2026-01-16250CALL0 056.63TRUE00
2026-01-1627.50CALL0 053.85TRUE00
2026-01-16307CALL0 653.93TRUE00
2026-01-1632.50CALL0 153.45FALSE00
2026-01-16353.8CALL0 152.91FALSE00
2026-01-1637.50CALL0 051.96FALSE00
2026-01-16400CALL0 349.91FALSE00
2026-01-1642.51.9CALL0 149.65FALSE00
2026-01-16451.75CALL0 150.86FALSE00
2026-01-1647.51.5CALL0 052.15FALSE00
2026-01-16150.5PUT0 181.62FALSE00
2026-01-1617.50PUT0 085.16FALSE00
2026-01-16200.8PUT0 274.77FALSE00
2026-01-1622.50PUT0 067.12FALSE00
2026-01-16250PUT0 061.01FALSE00
2026-01-1627.50PUT0 059.8FALSE00
2026-01-16305PUT0 158.6FALSE00
2026-01-1632.50PUT0 056.61TRUE00
2026-01-16350PUT0 056.57TRUE00
2026-01-1637.50PUT0 056.93TRUE00
2026-01-16400PUT0 054.66TRUE00
2026-01-1642.50PUT0 052.38TRUE00
2026-01-16450PUT0 050.74TRUE00
2026-01-1647.50PUT0 049.36TRUE00

Latest XENE Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$27.26
Jun 13, 2022 7:59 PM EST89$27.26
Jun 13, 2022 7:59 PM EST5$27.24
Jun 13, 2022 7:59 PM EST3$27.24
Jun 13, 2022 7:59 PM EST26$27.24

Xenon Pharmaceuticals Inc (XENE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520001824/0000921895-20-001824-index.htm
2019-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1582313/000000000019012321/0000000000-19-012321-index.htm
2020-06-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1582313/000000000020005143/0000000000-20-005143-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000085874419000023/0000858744-19-000023-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924318030608/0000899243-18-030608-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319007264/0000899243-19-007264-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319008569/0000899243-19-008569-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000089924319014470/0000899243-19-014470-index.htm
2018-07-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266418002713/0000902664-18-002713-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266419000946/0000902664-19-000946-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266419001016/0000902664-19-001016-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000090266420000959/0000902664-20-000959-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189519000466/0000921895-19-000466-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520000548/0000921895-20-000548-index.htm
2020-06-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000092189520001824/0000921895-20-001824-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004459/0001171843-18-004459-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004460/0001171843-18-004460-index.htm
2018-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004461/0001171843-18-004461-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004695/0001171843-18-004695-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004795/0001171843-18-004795-index.htm
2018-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2018-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008430/0001171843-18-008430-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008471/0001171843-18-008471-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000117184318008556/0001171843-18-008556-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049538/0001209191-19-049538-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119049864/0001209191-19-049864-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050127/0001209191-19-050127-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050129/0001209191-19-050129-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050131/0001209191-19-050131-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050133/0001209191-19-050133-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050143/0001209191-19-050143-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050146/0001209191-19-050146-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050164/0001209191-19-050164-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050166/0001209191-19-050166-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050169/0001209191-19-050169-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050172/0001209191-19-050172-index.htm
2019-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119050588/0001209191-19-050588-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119059515/0001209191-19-059515-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919119060910/0001209191-19-060910-index.htm
2020-01-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120003271/0001209191-20-003271-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120003273/0001209191-20-003273-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018941/0001209191-20-018941-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018951/0001209191-20-018951-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018958/0001209191-20-018958-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018963/0001209191-20-018963-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120018969/0001209191-20-018969-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120032628/0001209191-20-032628-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033588/0001209191-20-033588-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033593/0001209191-20-033593-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033596/0001209191-20-033596-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033605/0001209191-20-033605-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033627/0001209191-20-033627-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033639/0001209191-20-033639-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033643/0001209191-20-033643-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033653/0001209191-20-033653-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120033669/0001209191-20-033669-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120035608/0001209191-20-035608-index.htm
2020-08-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120046970/0001209191-20-046970-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120046974/0001209191-20-046974-index.htm
2020-08-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120048095/0001209191-20-048095-index.htm
2020-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120056222/0001209191-20-056222-index.htm
2020-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2020-11-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120057205/0001209191-20-057205-index.htm
2020-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1582313/000120919120057208/0001209191-20-057208-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000121390020003603/0001213900-20-003603-index.htm
2018-06-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000142284918000162/0001422849-18-000162-index.htm
2018-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000142284918000178/0001422849-18-000178-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018015497/0001564590-18-015497-index.htm
2018-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018016554/0001564590-18-016554-index.htm
2018-07-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018016768/0001564590-18-016768-index.htm
2018-07-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018016771/0001564590-18-016771-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018020000/0001564590-18-020000-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018020005/0001564590-18-020005-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018020018/0001564590-18-020018-index.htm
2018-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022422/0001564590-18-022422-index.htm
2018-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022703/0001564590-18-022703-index.htm
2018-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018022911/0001564590-18-022911-index.htm
2018-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018023027/0001564590-18-023027-index.htm
2018-09-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018023031/0001564590-18-023031-index.htm
2018-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018023099/0001564590-18-023099-index.htm
2018-09-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018023102/0001564590-18-023102-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459018027409/0001564590-18-027409-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459018027475/0001564590-18-027475-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019006512/0001564590-19-006512-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1582313/000156459019006514/0001564590-19-006514-index.htm
2019-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019006522/0001564590-19-006522-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019007593/0001564590-19-007593-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019009156/0001564590-19-009156-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019013752/0001564590-19-013752-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019016573/0001564590-19-016573-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019016580/0001564590-19-016580-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019021713/0001564590-19-021713-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019029412/0001564590-19-029412-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019029418/0001564590-19-029418-index.htm
2019-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1582313/000156459019029440/0001564590-19-029440-index.htm
2019-08-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1582313/000156459019031813/0001564590-19-031813-index.htm
2019-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019034466/0001564590-19-034466-index.htm
2019-09-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459019034720/0001564590-19-034720-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019040445/0001564590-19-040445-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019040449/0001564590-19-040449-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019040458/0001564590-19-040458-index.htm
2019-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459019040484/0001564590-19-040484-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459019044971/0001564590-19-044971-index.htm
2019-12-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1582313/000156459019045741/0001564590-19-045741-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020000685/0001564590-20-000685-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020000901/0001564590-20-000901-index.htm
2020-01-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020001642/0001564590-20-001642-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020001789/0001564590-20-001789-index.htm
2020-01-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020001790/0001564590-20-001790-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020009357/0001564590-20-009357-index.htm
2020-03-0910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1582313/000156459020009385/0001564590-20-009385-index.htm
2020-03-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020009391/0001564590-20-009391-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020010133/0001564590-20-010133-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020010811/0001564590-20-010811-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020019198/0001564590-20-019198-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020021912/0001564590-20-021912-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020026545/0001564590-20-026545-index.htm
2020-05-2110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026574/0001564590-20-026574-index.htm
2020-05-2210-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026739/0001564590-20-026739-index.htm
2020-05-2610-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020026807/0001564590-20-026807-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028137/0001564590-20-028137-index.htm
2020-06-03S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028139/0001564590-20-028139-index.htm
2020-06-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1582313/000156459020028142/0001564590-20-028142-index.htm
2020-06-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1582313/000156459020028884/0001564590-20-028884-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020037751/0001564590-20-037751-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020037862/0001564590-20-037862-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020037867/0001564590-20-037867-index.htm
2020-08-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020037893/0001564590-20-037893-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020040375/0001564590-20-040375-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1582313/000156459020051310/0001564590-20-051310-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1582313/000156459020051443/0001564590-20-051443-index.htm
2018-07-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000161577418006468/0001615774-18-006468-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1582313/000161577419002513/0001615774-19-002513-index.htm
2019-08-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1582313/999999999519001895/9999999995-19-001895-index.htm
2020-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1582313/999999999520001418/9999999995-20-001418-index.htm
2018-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999718007811/9999999997-18-007811-index.htm
2018-12-17CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999718009592/9999999997-18-009592-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999719006777/9999999997-19-006777-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999719006778/9999999997-19-006778-index.htm
2020-02-06SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1582313/999999999720000547/9999999997-20-000547-index.htm
2020-02-27SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1582313/999999999720001048/9999999997-20-001048-index.htm
2020-09-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1582313/999999999720004559/9999999997-20-004559-index.htm

Xenon Pharmaceuticals Inc (XENE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xenon Pharmaceuticals Inc (XENE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 658%
Institutional Ownership: 8130%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-20FRANK A HOLLERDirectorSell5,206.009.3948,884.34118,955.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-12SHERRINGTON ROBINEVP, Strategy & InnovationBuy6,172.003.0718,948.0412,064.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049538/0001209191-19-049538-index.htm
2019-09-12FRANK A HOLLERDirectorBuy3,086.003.7011,418.20122,041.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2020-05-29FRANK A HOLLERDirectorBuy3,086.003.5610,986.16122,041.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033588/0001209191-20-033588-index.htm
2019-09-19FRANK A HOLLERDirectorSell7,600.009.2770,452.00124,161.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050318/0001209191-19-050318-index.htm
2019-09-12FRANK A HOLLERDirectorBuy3,086.003.079,474.02124,193.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2019-09-18FRANK A HOLLERDirectorSell4,368.009.2840,535.04131,761.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-17FRANK A HOLLERDirectorSell5,069.009.3247,243.08136,129.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050136/0001209191-19-050136-index.htm
2019-09-12FRANK A HOLLERDirectorBuy25,720.003.0077,160.00148,979.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049550/0001209191-19-049550-index.htm
2020-06-01SHERRINGTON ROBINEVP, Strategy & InnovationBuy8,230.003.5629,298.8018,426.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033669/0001209191-20-033669-index.htm
2018-12-14GARY PATOUDirectorBuy2,057.003.076,314.9919,459.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318008471/0001171843-18-008471-index.htm
2018-06-14GARY PATOUDirectorBuy8,230.003.7030,451.0020,258.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004695/0001171843-18-004695-index.htm
2019-12-04GARY PATOUDirectorBuy2,057.003.567,322.9221,516.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119059515/0001209191-19-059515-index.htm
2020-10-28GARY PATOUDirectorBuy2,057.003.767,734.3223,573.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056222/0001209191-20-056222-index.htm
2020-06-01SIMON N. PIMSTONECEOSell3,000.0014.4343,290.00255,186.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2019-09-20SIMON N. PIMSTONECEOSell10,395.009.5198,856.45258,122.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050588/0001209191-19-050588-index.htm
2020-05-29SIMON N. PIMSTONECEOSell5,000.0013.9969,950.00258,186.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120033578/0001209191-20-033578-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy9,259.003.0728,425.13262,633.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy36,008.003.70133,229.60264,143.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2020-05-26SIMON N. PIMSTONECEOBuy6,172.003.5621,972.32264,294.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120032628/0001209191-20-032628-index.htm
2019-09-17SIMON N. PIMSTONECEOBuy12,345.003.3841,726.10272,209.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119050148/0001209191-19-050148-index.htm
2019-03-19Michael R HaydenDirectorBuy20,576.003.3869,546.8850,924.00https://www.sec.gov/Archives/edgar/data/1582313/000089924319008569/0000899243-19-008569-index.htm
2018-06-21MOHAMMAD AZABDirectorBuy10,288.003.7038,065.6054,498.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004795/0001171843-18-004795-index.htm
2019-09-13MOHAMMAD AZABDirectorSell23.009.31214.1857,561.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119049864/0001209191-19-049864-index.htm
2018-12-06MOHAMMAD AZABDirectorBuy3,086.003.079,474.0257,584.00https://www.sec.gov/Archives/edgar/data/1582313/000089924318030608/0000899243-18-030608-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy5,144.003.7019,032.8060,311.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-12-16MOHAMMAD AZABDirectorBuy3,086.003.5610,986.1660,647.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119060910/0001209191-19-060910-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy2,057.003.667,528.6262,368.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-05-21MICHAEL M TARNOWDirectorBuy2,057.003.216,602.9764,569.00https://www.sec.gov/Archives/edgar/data/1582313/000089924319014470/0000899243-19-014470-index.htm
2019-11-21MICHAEL M TARNOWDirectorBuy2,057.003.517,220.0766,626.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2018-06-21MICHAEL M TARNOWDirectorBuy5,144.003.0715,792.0867,512.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318004796/0001171843-18-004796-index.htm
2019-11-21MICHAEL M TARNOWDirectorBuy5,144.003.5618,312.6469,713.00https://www.sec.gov/Archives/edgar/data/1582313/000120919119057754/0001209191-19-057754-index.htm
2020-06-09MICHAEL M TARNOWDirectorBuy5,144.003.5218,106.8869,713.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120035608/0001209191-20-035608-index.htm
2020-10-28MICHAEL M TARNOWDirectorBuy5,144.003.7619,341.4474,857.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2020-10-28MICHAEL M TARNOWDirectorBuy5,144.003.7619,341.4480,001.00https://www.sec.gov/Archives/edgar/data/1582313/000120919120056229/0001209191-20-056229-index.htm
2018-12-11CHARLES J. COHENVP, BiologyBuy4,115.003.0712,633.058,194.00https://www.sec.gov/Archives/edgar/data/1582313/000117184318008430/0001171843-18-008430-index.htm